









市場
/
株式
/
nasdaq-lnth
/

Lantheus Holdings Inc

LNTH

74.410USD

-6.850-8.43%

終値 07/16, 16:00（ET）15分遅れの株価

5.15B時価総額

20.23直近12ヶ月PER



Lantheus Holdings Inc

74.410

-6.850-8.43%

概要企業名金融

Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow diseases to deliver patient outcomes. It classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Radiopharmaceutical Oncology diagnostics and therapeutics help healthcare professionals (HCPs) find, fight and follow cancer, with a focus on prostate cancer. Precision Diagnostic products assist HCPs to find and follow diseases, with a focus on cardiology. Strategic Partnerships focus on enabling precision medicine through the use of biomarker solutions, digital solutions, and radiotherapeutic platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, and others. Its clinical candidates include LNTH-2404, NAV-4694, and PNT2002, others. Its OCTEVY is a registrational-stage positron emission tomography (PET) diagnostic imaging agent targeting neuroendocrine tumors.

企業情報

企業コードLNTH

会社名Lantheus Holdings Inc

上場日Jun 25, 2015

設立日2007

最高経営責任者「CEO」Mr. Brian A. Markison

従業員数808

証券種類Ordinary Share

決算期末Jun 25

本社所在地331 Treble Cove Road

都市NORTH BILLERICA

証券取引所NASDAQ Global Market Consolidated

国United States of America

郵便番号01862

電話番号19786718001

ウェブサイトhttps://www.lantheus.com/

企業コードLNTH

上場日Jun 25, 2015

設立日2007

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Ms. Mary Anne Heino

Chairman of the Board

584.72K

-4.27%

Mr. Brian A. Markison

Chief Executive Officer, Director

232.42K

+35.31%

Ms. Amanda Morgan

Chief Commercial Officer

39.58K

+55.76%

Dr. Jean-Claude Provost, M.D.

Chief Scientific Officer

38.84K

-31.55%

Dr. James H. (Jim) Thrall

Independent Director

35.74K

+7.64%

Ms. Julie H. Mchugh

Lead Independent Director

25.96K

-16.67%

Dr. Gerard Ber, Ph.D.

Independent Director

23.36K

+10.09%

Ms. Minnie Baylor-Henry, J.D.

Independent Director

9.90K

+34.47%

Dr. Phuong Khanh (P. K.) Morrow, M.D.

Independent Director

3.10K

+450.62%

Mr. Samuel R. (Sam) Leno

Independent Director

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Ms. Mary Anne Heino

Chairman of the Board

584.72K

-4.27%

Mr. Brian A. Markison

Chief Executive Officer, Director

232.42K

+35.31%

Ms. Amanda Morgan

Chief Commercial Officer

39.58K

+55.76%

Dr. Jean-Claude Provost, M.D.

Chief Scientific Officer

38.84K

-31.55%

Dr. James H. (Jim) Thrall

Independent Director

35.74K

+7.64%

Ms. Julie H. Mchugh

Lead Independent Director

25.96K

-16.67%

収益内訳

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

PYLARIFY

257.65M

0.00%

DEFINITY

79.21M

0.00%

TechneLite

19.71M

0.00%

Strategic partnerships and other

10.75M

0.00%

Other precision diagnostics

5.44M

0.00%

Radiopharmaceutical oncology

0.00

0.00%

データなし

事業別

地域別

事業別USD

会社名

収益

比率

PYLARIFY

257.65M

0.00%

DEFINITY

79.21M

0.00%

TechneLite

19.71M

0.00%

Strategic partnerships and other

10.75M

0.00%

Other precision diagnostics

5.44M

0.00%

Radiopharmaceutical oncology

0.00

0.00%

株主

更新時刻: Wed, May 14

株主統計

種類

株主統計

比率

BlackRock Institutional Trust Company, N.A.

11.27%

The Vanguard Group, Inc.

10.10%

Janus Henderson Investors

9.05%

Farallon Capital Management, L.L.C.

8.71%

State Street Global Advisors (US)

3.81%

Other

57.07%

株主統計

比率

BlackRock Institutional Trust Company, N.A.

11.27%

The Vanguard Group, Inc.

10.10%

Janus Henderson Investors

9.05%

Farallon Capital Management, L.L.C.

8.71%

State Street Global Advisors (US)

3.81%

Other

57.07%

種類

株主統計

比率

Investment Advisor/Hedge Fund

53.47%

Investment Advisor

43.79%

Hedge Fund

11.55%

Research Firm

3.19%

Individual Investor

2.27%

Pension Fund

1.94%

Bank and Trust

1.35%

Sovereign Wealth Fund

0.57%

Family Office

0.09%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

1027

81.92M

118.40%

-3.35M

2025Q1

1066

83.20M

120.27%

-2.89M

2024Q4

1033

78.65M

114.86%

-4.64M

2024Q3

1003

73.69M

106.06%

-7.92M

2024Q2

959

71.82M

103.63%

-10.29M

2024Q1

912

71.21M

103.87%

-11.25M

2023Q4

868

73.50M

107.32%

-9.24M

2023Q3

828

74.80M

109.31%

-3.81M

2023Q2

790

72.85M

106.61%

-3.94M

2023Q1

733

71.94M

105.47%

-6.73M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

BlackRock Institutional Trust Company, N.A.

7.79M

11.27%

+17.69K

+0.23%

Mar 31, 2025

The Vanguard Group, Inc.

6.99M

10.1%

-242.63K

-3.36%

Mar 31, 2025

Janus Henderson Investors

6.26M

9.05%

-252.58K

-3.88%

May 30, 2025

Farallon Capital Management, L.L.C.

6.02M

8.71%

+707.00K

+13.30%

Mar 31, 2025

State Street Global Advisors (US)

2.64M

3.81%

-4.26K

-0.16%

Mar 31, 2025

Fidelity Management & Research Company LLC

2.17M

3.14%

+148.84K

+7.36%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.78M

2.57%

+94.57K

+5.62%

Mar 31, 2025

Westfield Capital Management Company, L.P.

1.59M

2.3%

+34.05K

+2.19%

Mar 31, 2025

T. Rowe Price Investment Management, Inc.

1.41M

2.04%

-96.91K

-6.42%

Mar 31, 2025

Reinhart Partners, LLC

1.21M

1.74%

-160.93K

-11.77%

Mar 31, 2025

詳細を見る